A leading pharmaceutical manufacturer aimed to reduce the burden on clinical trial participants and sites, improve access to a more diverse patient population, and accelerate trial outcomes. However, traditional trial models created significant challenges that limited efficiency and participation. Participants often faced barriers due to required in-person visits for medication dispensing, leading to scheduling difficulties and lower enrollment rates. Clinical trial sites were also burdened with administrative tasks, product handling, and storage responsibilities, which diverted attention from patient care and core research activities. These operational inefficiencies highlighted the need for a more patient-centric and streamlined trial approach that could enhance convenience, expand parti

Join for free to read